Neuromuscular ControlNCT07221305
RIIP REPS Neuromuscular Training
A study of Neuromuscular Control and Healthy, run by Hospital for Special Surgery, New York at 1 site in United States.
Trial summary
The purpose of this study is to assess both the feasibility and efficacy of a 6-week mobile-application-based neuromuscular training program in high school athletes by measuring adherence rates and examining changes in agility and neuromuscular control. Read more about this study
- Who is it for?
- Ages 14 to 18 yearsHealthy volunteers can take part
- Conditions the study is for
- Neuromuscular Control, Healthy, Athletic Performance and Injury Risk
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 19 participants
- Where
- 1 siteUnited States
- Study dates
- 2 Jul 2023to 29 Oct 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 14 to 18 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Who may be able to join
- Age 14-18
- Actively participating in an organized sport OR have participated in an organized sport in the last 12 months
- Pre-intervention testing completed AND post-intervention testing completed within 2 weeks of completing the 6 week program
Who cannot join
- Individuals whose physical activity and/or sports participation is currently limited by an illness or injury
- Individuals with previous lower extremity injury and/or surgery
- Individuals who are not fluent in English
- Individuals without access to an iOS or Android mobile phone
Trial locations and contacts
1 site in 1 country.
United States1 site
Hospital for Special Surgery
New York, New York, 10021
About this study
Official title: Feasibility and Efficacy of Delivering a Mobile Application-Based Neuromuscular Training Program to High School Athletes: Adherence, Agility, and Single Leg Squat Kinematics
The purpose of this study is to assess both the feasibility and efficacy of a 6-week mobile-application-based neuromuscular training program in high school athletes by measuring adherence rates and examining changes in agility and neuromuscular control. Outcomes were measured both during the intervention (adherence) as well as at pre- and post-intervention data collection sessions.
Read the detailed description
This study recruited high school athletes (ages 14-18) from Westchester County, NY to participate in a six week mobile application-based neuromuscular control training program that was downloaded onto each participant's personal smartphone and consisted of 24 unique 7-minute sessions. Pre/post intervention assessments included (1) an agility T test and (2) a video-recorded single leg squat test from sagittal and coronal planes. Sagittal plane analysis captured peak knee and hip flexion angles; coronal plane analysis assessed alignment of the knee, hips, and trunk. These subcomponent scores were combined into an 8-point composite movement quality score previously described by Di Paolo et al. Paired t-tests and effect sizes (Cohen's d) were computed to evaluate pre-post changes in agility T test performance and Di Paolo single leg squat composite and subcomponent scores. Participants were arranged by adherence into high (≥12 sessions) and low (<12 sessions) groups to determine if any relationship existed between adherence and outcome measures.
- Being tested
- Neuromuscular Control Training
- Keywords
- Neuromuscular Control Training, Injury Prevention, High School Athletes
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Neuromuscular Control TrainingOther
Also called Neuromuscular Training, NMT
The mobile app-based neuromuscular control training program was administered via the RIIP REPS application. The program consisted of 24 unique 7-minute sessions. Each session emphasized bodyweight training targeting landing mechanics, trunk and hip control, balance, and posterior chain engagement. The sessions progressed in difficulty throughout the intervention.
| Study group | Role | What they receive |
|---|---|---|
| Neuromuscular Control Training Program | Experimental | The intervention was a self-paced neuromuscular control training program that athletes completed on their mobile phones via the RIIP REPS app. Athletes were instructed to complete 4 sessions per week throughout the 6 week intervention. Receives: Other: Neuromuscular Control Training |
What is being measured
The primary outcome is the main question the study is designed to answer.
Compliance
Compliance with the RIIP REPS mobile program was defined by how many sessions were completed by each participant. Full compliance consisted of the recommended four sessions per week for a total of 24 sessions over the 6 week period. Adherence tiers were determined based on the number of sessions completed and were as follows: low adherence (<12 sessions), and high adherence (>12 sessions).
Measured: Throughout the 6 week intervention
Secondary outcomes (2)
Movement Quality
Athletes completed a total of 12 single-leg squats (SLS), guided by trained sports medicine educators. The test protocol consisted of three SLS per leg in the frontal plane and three in the sagittal plane. In the frontal plane, the athlete faced the camera; for the sagittal plane, the athlete turned 90 degrees, maintaining the same squatting leg toward the camera. If a participant lost balance during a repetition, they were instructed to repeat the squat to ensure three successful trials per view. Videos were then analyzed based on the criteria set forth by Di Paolo et al. and the measurements were then used to compute a composite score (0 through 8) with a higher score indicating better performance.
Measured: Testing was performed before and within 2 weeks after the 6 week intervention.
Agility T Test
The T test is a widely used measure of change-of-direction speed and agility, consisting of a T-shaped running course that challenges lateral, forward, and backward movement. Athletes began at the base of the "T," sprinted forward 10 yards to touch a central cone, shuffled 5 yards to one side to touch another cone, shuffled 10 yards laterally to the opposite side to touch a second cone, returned to the center cone via shuffle, and then backpedaled to the starting point. Proper technique and cone touches were required for a valid trial. To ensure timing accuracy, each trial was independently timed by two study personnel using handheld stopwatches. The average of the two recorded times was used for analysis.
Measured: Testing was performed before and within 2 weeks after the 6 week intervention.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Oct 2025
- Study start2 Jul 2023
- Primary completion22 Oct 2023
- Study completion29 Oct 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for Neuromuscular ControlStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 19 participants (actual)
Sponsor and investigators
- Lead sponsor
- Hospital for Special Surgery, New York
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Andrew D Pearle, M.D., Principal investigator, Hospital for Special Surgery, New York
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07221305
- Sponsor's protocol ID
- IRB #2023-0499
- Status last verified
- Oct 2025
- First submitted
- 23 Oct 2025
- Last updated
- 30 Oct 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Petushek EJ, Sugimoto D, Stoolmiller M, Smith G, Myer GD. Evidence-Based Best-Practice Guidelines for Preventing Anterior Cruciate Ligament Injuries in Young Female Athletes: A Systematic Review and Meta-analysis. Am J Sports Med. 2019 Jun;47(7):1744-1753. doi: 10.1177/0363546518782460. Epub 2018 Jul 12.
PubMed 30001501Steib S, Rahlf AL, Pfeifer K, Zech A. Dose-Response Relationship of Neuromuscular Training for Injury Prevention in Youth Athletes: A Meta-Analysis. Front Physiol. 2017 Nov 14;8:920. doi: 10.3389/fphys.2017.00920. eCollection 2017.
PubMed 29184511Di Paolo S, Musa F, d'Orsi GM, Grassi A, Vulpiani MC, Zaffagnini S, Della Villa F. A comprehensive two-dimensional scoring system to assess the single-leg squat task in football players. Knee. 2024 Jun;48:52-62. doi: 10.1016/j.knee.2024.02.016. Epub 2024 Mar 20.
PubMed 38513322
Study at a glance
From the registry record, last updated by the sponsor on 30 Oct 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Feasibility and Efficacy of Delivering a Mobile Application-Based Neuromuscular Training Program to High School Athletes: Adherence, Agility, and Single Leg Squat Kinematics
- ClinicalTrials.gov ID
- NCT07221305
- Acronym / sponsor ID
- IRB #2023-0499
- Keywords
- Neuromuscular Control Training, Injury Prevention, High School Athletes
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 19 participants (actual)
- Lead sponsor
- Hospital for Special Surgery, New YorkUniversity, hospital or other
- Study start
- 2 Jul 2023 (actual)
- Primary completion
- 22 Oct 2023 (actual)
- Study completion
- 29 Oct 2023 (actual)
- First posted
- 27 Oct 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to assess both the feasibility and efficacy of a 6-week mobile-application-based neuromuscular training program in high school athletes by measuring adherence rates and examining changes in agility and neuromuscular control. Outcomes were measured both during the intervention (adherence) as well as at pre- and post-intervention data collection sessions.
Detailed description
This study recruited high school athletes (ages 14-18) from Westchester County, NY to participate in a six week mobile application-based neuromuscular control training program that was downloaded onto each participant's personal smartphone and consisted of 24 unique 7-minute sessions. Pre/post intervention assessments included (1) an agility T test and (2) a video-recorded single leg squat test from sagittal and coronal planes. Sagittal plane analysis captured peak knee and hip flexion angles; coronal plane analysis assessed alignment of the knee, hips, and trunk. These subcomponent scores were combined into an 8-point composite movement quality score previously described by Di Paolo et al. Paired t-tests and effect sizes (Cohen's d) were computed to evaluate pre-post changes in agility T test performance and Di Paolo single leg squat composite and subcomponent scores. Participants were arranged by adherence into high (≥12 sessions) and low (<12 sessions) groups to determine if any relationship existed between adherence and outcome measures.
Study design
- Primary purpose
- Prevention
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Neuromuscular Control Training Program | Experimental | Other: Neuromuscular Control TrainingThe intervention was a self-paced neuromuscular control training program that athletes completed on their mobile phones via the RIIP REPS app. Athletes were instructed to complete 4 sessions per week throughout the 6 week intervention. |
Who may qualify
- Ages
- 14 to 18 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
Key inclusion criteria (3 listed)
- Age 14-18
- Actively participating in an organized sport OR have participated in an organized sport in the last 12 months
- Pre-intervention testing completed AND post-intervention testing completed within 2 weeks of completing the 6 week program
Key exclusion criteria (4 listed)
- Individuals whose physical activity and/or sports participation is currently limited by an illness or injury
- Individuals with previous lower extremity injury and/or surgery
- Individuals who are not fluent in English
- Individuals without access to an iOS or Android mobile phone
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Neuromuscular Control TrainingAlso: Neuromuscular Training, NMTThe mobile app-based neuromuscular control training program was administered via the RIIP REPS application. The program consisted of 24 unique 7-minute sessions. Each session emphasized bodyweight training targeting landing mechanics, trunk and hip control, balance, and posterior chain engagement. The sessions progressed in difficulty throughout the intervention. | Other | Neuromuscular Control Training Program |
Primary outcome
Compliance
Time frame: Throughout the 6 week intervention
Compliance with the RIIP REPS mobile program was defined by how many sessions were completed by each participant. Full compliance consisted of the recommended four sessions per week for a total of 24 sessions over the 6 week period. Adherence tiers were determined based on the number of sessions completed and were as follows: low adherence (<12 sessions), and high adherence (>12 sessions).
2 secondary outcomes
Movement Quality
Time frame: Testing was performed before and within 2 weeks after the 6 week intervention.
Agility T Test
Time frame: Testing was performed before and within 2 weeks after the 6 week intervention.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Oct 2025.
- Background: PubMed 30001501Petushek EJ, Sugimoto D, Stoolmiller M, Smith G, Myer GD. Evidence-Based Best-Practice Guidelines for Preventing Anterior Cruciate Ligament Injuries in Young Female Athletes: A Systematic Review and Meta-analysis. Am J Sports Med. 2019 Jun;47(7):1744-1753. doi: 10.1177/0363546518782460. Epub 2018 Jul 12.
- Background: PubMed 29184511Steib S, Rahlf AL, Pfeifer K, Zech A. Dose-Response Relationship of Neuromuscular Training for Injury Prevention in Youth Athletes: A Meta-Analysis. Front Physiol. 2017 Nov 14;8:920. doi: 10.3389/fphys.2017.00920. eCollection 2017.
- Background: PubMed 38513322Di Paolo S, Musa F, d'Orsi GM, Grassi A, Vulpiani MC, Zaffagnini S, Della Villa F. A comprehensive two-dimensional scoring system to assess the single-leg squat task in football players. Knee. 2024 Jun;48:52-62. doi: 10.1016/j.knee.2024.02.016. Epub 2024 Mar 20.
- Individual participant dataSharing planned: No
Related trials for Neuromuscular Control
RecruitingPhase 3
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
Chronic Inflammatory Demyelinating Polyneuropathy, CIDP
RecruitingPhase 2
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
Multiple Sclerosis Spasticity
Not yet recruiting
Selective Nerve Root Block Versus Sham to Reduce Surgery for Lumbar Disc Herniation
Lumbar Disc Herniation, Lumbar Radiculopathy
RecruitingPhase 3
A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
Ocular Myasthenia Gravis
RecruitingPhase 2
FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)
Dermatomyositis (DM), Juvenile Dermatomyositis (JDM)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Andrew D Pearle, M.D. principal investigator
Hospital for Special Surgery, New York
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study of Neuromuscular Control and Healthy, run by Hospital for Special Surgery, New York at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 30 Oct 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Compliance (time frame: Throughout the 6 week intervention). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07221305, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Oct 2025.